Association of CYP3A5 genotypes with blood pressure and renal function in African families

Journal of Hypertension

Volumn 24, Issue 5, 2006, Pages 923-929

  Bochud, Murielle ^a,b   Eap, Chin B ^c   Elston, Robert C ^a   Bovet, Pascal ^b,d   Maillard, Marc ^e   Schild, Laurent ^f   Shamlaye, Conrad ^d   Burnier, Michel ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

^d Ministry of Health   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Africans; Blood pressure; CYP3A5; Family based association study; Glomerular filtration rate; Sodium

Indexed keywords

CYTOCHROME P450 3A5;

ADULT; AFRICA; AGED; ALLELE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; PEDIGREE; PRIORITY JOURNAL; SODIUM TRANSPORT;

EID: 33646359696     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000222763.84605.4a     Document Type: Article

References (30)

1. Nebert DW, Russell DW. Clinical importance of the cytochromes P450. Lancet 2002; 360:1155-1162.
2. Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, et al. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics 2001; 11:111-121.
3. Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, et al. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 1990; 38:207-213.
4. Boobis AR, Edwards RJ, Adams DA, Davies DS. Dissecting the function of cytochrome P450. Br J Clin Pharmacol 1996; 42:81-89.
5. Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, et al. CYP3A gene expression in human gut epithelium. Pharmacogenetics 1994; 4:247-259.
6. Haehner BD, Gorski JC, Vandenbranden M, Wrighton SA, Janardan SK, Watkins PB, et al. Bimodal distribution of renal cytochrome P450 3A activity in humans. Mol Pharmacol 1996; 50:52-59.
7. Koch I, Weil R, Wolbold R, Brockmoller J, Hustert E, Burk O, et al. Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab Dispos 2002; 30:1108-1114.
8. Schuetz EG, Schuetz JD, Grogan WM, Naray-Fejes-Toth A, Fejes-Toth G, Raucy J, et al. Expression of cytochrome P450 3A in amphibian, rat, and human kidney. Arch Biochem Biophys 1992; 294:206-214.
9. Ghosh SS, Basu AK, Ghosh S, Hagley R, Kramer L, Schuetz J, et al. Renal and hepatic family 3A cytochromes P450 (CYP3A) in spontaneously hypertensive rats. Biochem Pharmacol 1995; 50:49-54.
10. Watlington CO, Kramer LB, Schuetz EG, Zilai J, Grogan WM, Guzelian P, et al. Corticosterone 6 beta-hydroxylation correlates with blood pressure in spontaneously hypertensive rats. Am J Physiol 1992; 262:F927-F931.
11. Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 2001; 27:383-391.
12. Paulussen A, Lavrijsen K, Bohets H, Hendrickx J, Verhasselt P, Luyten W, et al. Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans. Pharmacogenetics 2000; 10:415-424.
13. Hustert E, Haberl M, Burk O, Wolbold R, He YQ, Klein K, et al. The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics 2001; 11:773-779.
14. Thompson EE, Kuttab-Boulos H, Witonsky D, Yang L, Roe BA, Di Rienzo A. CYP3A variation and the evolution of salt-sensitivity variants. Am J Hum Genet 2004; 75:1059-1069.
15. Givens RC, Lin YS, Dowling AL, Thummel KE, Lamba JK, Schuetz EG, et al. CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults. J Appl Physiol 2003; 95:1297-1300.
16. Ho H, Pinto A, Hall SD, Flockhart DA, Li L, Skaar TC, et al. Association between the CYP3A5 genotype and blood pressure. Hypertension 2005; 45:1-5.
17. Bochud M, Elston RC, Maillard M, Bovet P, Schild L, Burnier M. Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean). Kidney Int 2005; 67:61-69.
18. Bochud M, Bovet P, Elston RC, Paccaud F, Falconnet C, Shamlaye C, et al. High heritability of ambulatory blood pressure in families of East African descent. Hypertension 2005; 45:445-450.
19. Poulsen K, Jorgensen J. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Metab 1974; 39:816-825.
20. DuBois M, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17:863-871.
21. Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M. Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertension 2000; 36:631-637.
22. S.A.G.E. Statistical Analysis for Genetic Epidemiology v5.0. Cleveland Ohio: Department of Epidemiology and Biostatistics, Case Western Reserve University; 2004.
23. George VH, Tiwari X, Zhu X, Elston RC. A test of transmission/ disequilibrium for quantitative trait loci in pedigree data, by multiple regression. Am J Hum Genet 1999; 65:236-245.
24. van Schaik RHN, van der Heiden IP, van den Anker JN, Lindemans J. CYP3A5 variant allele frequencies in Dutch Caucasians. Clin Chem 2002; 48:1668-1671.
25. Warrington JS, Greenblatt DJ, von Moltke LL. Age-related differences in CYP3A expression and activity in the rat liver, intestine, and kidney. J Pharmacol Exp Ther 2004; 309:720-729.
26. Centonza L, Castoldi G, Chianca R, Busca G, Golin R, Zanchetti A, et al. Short-term analysis of the relationship between blood pressure and urinary sodium excretion in normotensive subjects. Clin Sci (Lond) 2000; 98:495-500.
27. Staessen JA, Birkenhager W, Bulpitt CJ, Fagard R, Fletcher AE, Lijnen P, et al. The relationship between blood pressure and sodium and potassium excretion during the day and at night. J Hypertens 1993; 11:443-447.
28. Staessen J, Broughton PM, Fletcher AE, Markowe HL, Marmot MG, Rose G, et al. The assessment of the relationship between blood pressure and sodium intake using whole-day, daytime and overnight urine collections. J Hypertens 1991; 9:1035-1040.
29. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 1991; 18:67-71.
30. Patki KC, von Moltke LL, Greenblatt DJ. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5. Drug Metab Dispos 2003; 31:938-944.